ScandicNeuro Corp

The treatment gap in the U.S. underpins nearly every employer mental health conversation. SAMHSA’s 2024 National Survey on Drug Use and Health found that 61.5 million adults (23.4% of the US adult population) experienced any mental illness in 2024, yet only about 52% received treatment. That means roughly 29.5 million adults with a diagnosable condition received no care. Access and insurance coverage remain a core problem.

Mental health utilization is up - but employer spending fell 7% in 2025 The gap between rising demand and falling investment is widening, and brokers have a clear role at renewal

Alzheimer's Disease trial recruitment was consistently characterized as a multi-stage, interconnected process that includes participant identification, outreach, pre-screening, engagement, screening, and retention by the five interview groups in this study. It was noted that no single strategy or tool was considered adequate to guarantee successful recruitment.

Fixing the Funnel: Stakeholder Insights on Alzheimer’s Disease Trial Recruitment - August 7, 2026 - USC Schaeffer Interviews with stakeholders across the Alzheimer’s clinical trial ecosystem explored barriers, emerging practices and opportunities to improve recruitment. - August 7, 2026

The FDA has just approved a wireless brain implant for severe depression—imagine it as your brain’s first true smart upgrade. It takes 20 minutes to implant in an outpatient clinic, and it’s not a bulky medical gadget; it’s even smaller than an AirPod and operates without batteries or wires running through your head.

FDA Just Cleared the First Wireless Brain Implant for Severe Depression Brain implant gets FDA clearance for first wireless depression treatment trial, offering battery-free stimulation in 20-minute outpatient procedure.

Exciting News! - ScandicNeuro Exciting News! Exciting News! April 21, 2026 s11admin Exciting news! Dr. Dobson felt both honored and humbled to be named an inaugural Fellow of the International Neuropsychological Society (INS) at the 2026 INS Annual Conference in Philadelphia, in the company of many distinguished and highly respe...

In what ways can neuropsychology add value to global clinical trial research?

In what ways can neuropsychology add value to global clinical trial research? - ScandicNeuro In what ways can neuropsychology add value to global clinical trial research? In what ways can neuropsychology add value to global clinical trial research? March 4, 2026 s11admin In what ways can neuropsychology add value to global clinical trial research? Neuropsychology supports global clinical tr...

Happy New Year!
We wish you prosperity and success in the New Year and look forward to an exciting and inspiring 2026!

A study from the University of Pittsburgh and UPMC Children’s Hospital has identified an epigenetic signature to help track and improve recovery after pediatric traumatic brain injury (TBI). Published in the Journal of Neurotrauma, it’s the first to reveal DNA changes that distinguish children with complicated mild to severe TBI from those with non-neurological injuries.
https://www.health.pitt.edu/news/pitt-study-finds-signature-pediatric-brain-injury

Scientists have built the first “artificial neuron” made from a metal–organic framework (M*F) that can behave like real brain cells in water by responding to dopamine. Unlike traditional electronic devices, this M*F neuron can carry out brain-like tasks such as learning through synaptic plasticity, sending integrate-and-fire signals, and adjusting its activity based on dopamine levels.

To demonstrate its capabilities, the team utilized the neuron to control a robotic hand. The amount of dopamine present determined how fast and how strongly the hand moved. This breakthrough brings artificial neurons a significant step closer to functioning like biological ones, opening up exciting possibilities for brain-inspired computers, smart biosensors, and advanced prosthetic devices.

A metal–organic framework neuron This study presents the first metal-organic framework neuron with real neurotransmitter dopamine tunable spikes for neuromorphic engineering.

We need to improve mental health at the individual and societal levels. Despite progress in awareness and destigmatization, significant challenges remain in prevention, access to care, and support for those affected.


https://scandicneuro.com/2025/04/the-need-to-improve-mental-health/